Worldwide disparities in cardiovascular disease: challenges and solutions

IS Okwuosa, SC Lewsey, T Adesiyun… - International journal of …, 2016 - Elsevier
The 20th century saw cardiovascular disease ascend as the leading cause of death in the
world. In response to the new challenge that heart disease imposed, the cardiovascular …

Efficacy of intravenous furosemide versus a novel, pH-neutral furosemide formulation administered subcutaneously in outpatients with worsening heart failure

NA Gilotra, O Princewill, B Marino, IS Okwuosa… - JACC: Heart Failure, 2018 - jacc.org
Objectives : This study sought to determine the efficacy and safety of a novel, pH-neutral
formulation of furosemide administered subcutaneously (SC) for treatment of acute …

Patients commonly believe their heart failure hospitalizations are preventable and identify worsening heart failure, nonadherence, and a knowledge gap as reasons …

NA Gilotra, A Shpigel, IS Okwuosa, R Tamrat… - Journal of cardiac …, 2017 - Elsevier
Background There are few data describing patient-identified precipitants of heart failure (HF)
hospitalization. We hypothesized a patient's perception of reason for or preventability of an …

Disparities in cardiovascular care: Past, present, and solutions.

…, O Princewill, T Shobayo, IS Okwuosa - … Clinic journal of …, 2019 - europepmc.org
Cardiovascular disease has been the leading cause of death in the United States since the
early 20th century. With advances in prevention and treatment, cardiovascular mortality rates …

Innovations in Undergraduate Research Training Through Multisite Collaborative Programming: American Heart Association Summer Undergraduate Research …

TB Ajayi, AL Mueller, IS Okwuosa… - Journal of the …, 2022 - Am Heart Assoc
Background To support diversity in biomedical science, the American Heart Association
launched the Supporting Undergraduate Research Experiences for undergraduate students …

Cardiac transplantation outcomes in patients with amyloid cardiomyopathy

…, DT Pham, JD Rich, CW Yancy, IS Okwuosa - American heart …, 2021 - Elsevier
Objective Amyloid cardiomyopathy (ACM) is a progressive and life-threatening disease caused
by abnormal protein deposits within cardiac tissue. The most common forms of ACM are …

Hyponatremia Is a Powerful Predictor of Poor Prognosis in Left Ventricular Assist Device Patients

…, R Harap, K Ghafourian, JE Wilcox, IS Okwuosa… - ASAIO …, 2022 - journals.lww.com
Serum sodium is an established prognostic marker in heart failure (HF) patients and is
associated with an increased risk of morbidity and mortality. We sought to study the prognostic …

Heart transplantation outcomes in cardiac sarcoidosis

…, S Russell, PHS Sporn, CW Yancy, IS Okwuosa - The Journal of Heart and …, 2022 - Elsevier
Background Cardiac sarcoidosis (CS) is a progressive inflammatory cardiomyopathy that
can lead to heart failure, arrhythmia, and death. There is limited data on Orthotopic Heart …

[PDF][PDF] The ABCs of managing systolic heart failure: past, present, and future

IS Okwuosa, O Princewill, C Nwabueze… - Cleve Clin J …, 2016 - scholar.archive.org
Heart failure management is complex and constantly evolving. The American College of
Cardiology and the American Heart Association (ACC/AHA) last issued evidence-based …

The heart transplant allocation change attenuates but does not eliminate blood group O waitlist outcome disadvantage

…, D Abramov, M Fudim, IS Okwuosa… - Clinical …, 2022 - Wiley Online Library
Background Patients with blood group O have historically been disadvantaged in the United
Network for Organ Sharing (UNOS) heart transplant allocation system. We sought to …